3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Conditions
Motor Activity
13
Neoplasms
9
Lung Neoplasms
3
Breast Neoplasms
3
Stomach Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pancreatic Neoplasms
2
Disease
2
Urinary Bladder Neoplasms
1
Rectal Neoplasms
1
Psychological Well-Being
1
Prostatic Neoplasms
1
Personal Satisfaction
1
Peripheral Nervous System Diseases
1
Pelvic Floor Disorders
1
Ovarian Neoplasms
1
Obesity
1
Neoplasm Metastasis
1
Myeloproliferative Disorders
1
Muscular Atrophy
1
Mesothelioma
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Esophageal Neoplasms
1
Edema
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Cardiotoxicity
1
Carcinoma, Non-Small-Cell Lung
1
Cancer Patients
1
Cachexia
1
Interventions
peginterferon alfa-2b
1
Specimen Handling
1
Resistance Training
1
Quality of Life
1
Phlebotomy
1
Observation
1
Maintenance
1
Levofloxacin
1
Exercise
1
Electrocardiography
1
Echocardiography
1
Clinical Laboratory Techniques
1
Busulfan
1
Bone Marrow Examination
1
Biopsy
1
Azacitidine
1
Aspirin
1
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Myeloproliferative Disorders
×
Exercise
×
Clear all
NCT07384039
2026-02-05
MPN-Exercise
Hannover Medical School
Phase NA
Not yet recruiting
80 enrolled